(HealthDay)—Lowering of plasma uric acid (PUA) with febuxostat (FBX) is associated with a modest reduction in systolic blood pressure (BP) in patients with type 1 diabetes mellitus (T1DM), according to a study published ...
Apr 26, 2017
0
0
(HealthDay)—Continuous glucose monitoring (CGM) contributes to significant improvements in diabetes-specific quality of life (QOL) measures among adults with type 1 diabetes mellitus (T1DM), according to a study published ...
Apr 14, 2017
0
1
(HealthDay)—Maternal hyperglycemia during pregnancy is associated with increased risk of abnormal glucose tolerance, obesity, and increased blood pressure (BP) in offspring, independent of maternal obesity, according to ...
Mar 20, 2017
0
0
(HealthDay)—For patients with suboptimally controlled type 1 diabetes mellitus (T1DM), metreleptin does not improve glycemic control, but is associated with reductions in body weight and daily insulin dose, according to ...
Mar 7, 2017
0
0
Diabetes can have several complications, including one common side effect: foot damage. Although some types are common, others are rarer.
Feb 23, 2017
0
11
People infected with HIV may be more susceptible to developing diabetes, suggests research published in the online journal BMJ Open Diabetes Research & Care.
Jan 30, 2017
0
3
A new report, based on data from the Framingham Heart Study (FHS), suggests that insulin resistance, a predictor of cardiovascular risk and the development of diabetes, may be modulated with even modest levels of physical ...
Jan 26, 2017
0
0
A study by Japan's Tokohu University researchers has identified two new types of microRNA (miRNA) that improved hyperglycemia in a mouse model of diabetes by stimulating the proliferation of insulin-producing pancreatic beta ...
Jan 23, 2017
0
0
(HealthDay)—For patients with gestational diabetes mellitus (GDM), glyburide and metformin are comparable in terms of glucose control and safety, according to a study published online Jan. 11 in Diabetes Care.
Jan 17, 2017
0
0
(HealthDay)—For overweight and obese adults with diabetes mellitus, a long-term intensive lifestyle intervention does not offer cognitive benefits, according to a study published online Jan. 9 in the Journal of the American ...
Jan 12, 2017
0
0
